ReviewDrug design, development and therapy2014

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.

Jacqueline Ann Nicholas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.